(Q33669639)

28 July 2017

title

Adverse effects of thalidomide administration, in patients with myeloma multiplex? (English)

1 reference

28 July 2017

0 references

Krstevska Svetlana Balkanov

1

1 reference

28 July 2017

Tatjana Sotirova

2

1 reference

28 July 2017

Stavrik Sonja Genadieva

3

1 reference

28 July 2017

Lidija Cevreska

4

1 reference

28 July 2017

Aleksandar Stojanovik

5

1 reference

28 July 2017

Trajan Balkanov

6

1 reference

28 July 2017

publication date

11 April 2014

1 reference

28 July 2017

1 reference

28 July 2017

volume

26

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

134-136

1 reference

International uniform response criteria for multiple myeloma.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Treatment of plasma cell dyscrasias with thalidomide and its derivatives

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Antitumor activity of thalidomide in refractory multiple myeloma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

Deep venous thrombosis and thalidomide therapy for multiple myeloma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035132

30 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944541

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5455/MSM.2014.26.134-136

1 reference

release_ifj5nhpi6jgf5gj7tgz4ljkh5u

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ifj5nhpi6jgf5gj7tgz4ljkh5u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

4035132

1 reference

28 July 2017

1 reference